RNA Operating Cash Flow (Statement)
Atrium Therapeutics Inc · Operating Cash Flow (Statement)
RNA Operating Cash Flow (Statement)
Latest reported-$41.13Mperiod ending
RNA FY Cash from Operations (-$41.13M → -$41.13M)
Annual operating cash flow (statement)
More history is needed to export this chart.
RNA operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -41,129,000 |